Accelerated PrEP Access for Black MSM and TW

• Status: Not yet recruiting
• Trial end date: 2021-07-31
• Target enrollment: 0
• Participant gender: Male

Summary

The investigators will pilot-test an accelerated PrEP initiation approach among young high-risk Black/African American (B/AA) men who have sex with men (MSM) and transgender women (YMSM/TW) at the point of care in community contexts.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Chicago
• Collaborator: Planned Parenthood Great Plains
• Treatments: Emtricitabine; Tenofovir

Criteria

Inclusion Criteria:

1. ages 18-24;

2. assigned male at birth, identify as a man (cisgender), transgender woman, or gender non-conforming or genderqueer;

3. identifying as Black, African American, or multiracial with at least one parent identifying as Black or African American;

4. not currently taking PrEP or attending a visit to initiate PrEP;

5. self-report being HIV-negative;

6. reporting one of the following HIV risks in the last 6 months (Hosek, Rudy et al. 2015, Hosek, Rudy et al. 2017): a. condomless anal intercourse with an HIV-infected male partner or a male partner of unknown HIV status; b. anal intercourse with 3 or more male sex partners; c. exchange of money, gifts, shelter, or drugs for anal sex with a male partner; d. sex with a male partner and has had a sexually transmitted infection; e. sexual partner of an HIV-infected male with whom condoms were not consistently used; f. anal intercourse where the condom broke or slipped off

Exclusion Criteria:

• We are excluding those individuals who were assigned female at birth (female birth certificate) and/or cis-gender women (those assigned female at birth and identify as women) from the all phases of this study as this study is intended to explore the HIV prevention behaviors of B/AA young men who have sex with men and young transgender women (assigned male at birth) as these two groups represent the highest risk groups for HIV infection in the US, yet only a small percentage are aware or currently use PrEP for HIV prevention.